Infliximab for paradoxical reactions in pediatric central nervous system tuberculosis
Paradoxical reactions in central nervous system tuberculosis (CNS-TB) are associated with significant morbidity and mortality. We describe 4 HIV-uninfected children treated for CNS-TB with severe paradoxical reactions unresponsive to corticosteroids. All made recovery after treatment with infliximab...
Main Authors: | Abo, Y-N, Curtis, N, Osowicki, J, Haeusler, G, Purcell, R, Kadambari, S, De Wachter, M, Vanden Driessche, K, Dekeyzer, S, Coleman, L, Crawford, N, Graham, S, Marais, B, Gwee, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2021
|
Similar Items
-
Paradoxical skin reaction with infliximab treatment
by: Larissa Starling de A. Fernandes, et al.
Published: (2018-09-01) -
Decrease in infection-related hospital admissions during COVID-19: why are parents avoiding the doctor?
by: Kadambari, S, et al.
Published: (2020) -
Outcomes of low-dose infliximab as an adjunctive therapy in patients with severe central nervous system tuberculosis
by: Dr Selwyn Selvakumar, et al.
Published: (2025-03-01) -
Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab
by: Mehmet Unlu, et al.
Published: (2014-01-01) -
Immune Vulnerability of Infants to Tuberculosis
by: Koen Vanden Driessche, et al.
Published: (2013-01-01)